Home
Home

lymphoma

News

Data Monitoring Committee Recommends Continuation Of Phase III Study Of StemEx(R), A Cord Blood Stem Cell Product, For Leukemia And Lymphoma
Medical News Today
»

News

Cell Therapeutics’ Last Hope for Survival, Dashed
Minyanville
»

News

FDA Raises Concerns About Cell Therapeutics' Cancer Drug
TheStreet.com
»

News

Cell Therapeutics Has Strange Timing
TheStreet.com
»

News

Cell Therapeutics Gets FDA Panel for Lymphoma Drug
TheStreet.com
»

News

Introducing the $30,000 Per Month Cancer Drug
WSJ Online
»

News

Patent issued for Allos Therapeutics' cancer drug Folotyn
Bizjournals.com
»

News

Seattle Genetics Halts Lymphoma Drug Study
TheStreet.com
»

News

FDA Approves Allos Lymphoma Drug
TheStreet.com
»

News

Rituxan tests positive in Phase III trial
Fierce Pharma
»